Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiqing Liao

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Drug Discovery Today. Technologies|January 3, 2016
Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitorsDaiqing Liao
Cell Chemical Biology|January 31, 2017
CBP/p300 Bromodomain Mediates Amyloid FormationDaiqing Liao
Molecular Cancer Research : MCR|December 10, 2009
Emerging roles of the EBF family of transcription factors in tumor suppressionDaiqing Liao
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Identification and characterization of small-molecule inhibitors of lysine acetyltransferasesDaiqing Liao
Frontiers in Pharmacology|February 16, 2026
Editorial: Next-generation PROTACs in oncology and beyond: exploring therapeutic targets and their degradersDaiqing Liao, Debasish Bandyopadhyay
Nucleic Acids Research|July 28, 2019
DAXX in cancer: phenomena, processes, mechanisms and regulationIqbal Mahmud, Daiqing Liao
Genomics Data|July 29, 2015
Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitorsIqbal Mahmud, Daiqing Liao
Journal of Visualized Experiments : Jove|August 25, 2020
Assays for Validating Histone Acetyltransferase InhibitorsAaron R Waddell, Daiqing Liao
Journal of Virology|December 4, 2003
Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosisLisa Y Zhao, Daiqing Liao
Cancers|July 2, 2021
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast CancersAaron R Waddell, Haojie Huang, Daiqing Liao
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Drug Discovery Today. Technologies|January 3, 2016
Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitorsDaiqing Liao
Cell Chemical Biology|January 31, 2017
CBP/p300 Bromodomain Mediates Amyloid FormationDaiqing Liao
Molecular Cancer Research : MCR|December 10, 2009
Emerging roles of the EBF family of transcription factors in tumor suppressionDaiqing Liao
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Identification and characterization of small-molecule inhibitors of lysine acetyltransferasesDaiqing Liao
Frontiers in Pharmacology|February 16, 2026
Editorial: Next-generation PROTACs in oncology and beyond: exploring therapeutic targets and their degradersDaiqing Liao, Debasish Bandyopadhyay
Nucleic Acids Research|July 28, 2019
DAXX in cancer: phenomena, processes, mechanisms and regulationIqbal Mahmud, Daiqing Liao
Genomics Data|July 29, 2015
Microarray gene expression profiling reveals potential mechanisms of tumor suppression by the class I HDAC-selective benzoylhydrazide inhibitorsIqbal Mahmud, Daiqing Liao
Journal of Visualized Experiments : Jove|August 25, 2020
Assays for Validating Histone Acetyltransferase InhibitorsAaron R Waddell, Daiqing Liao
Journal of Virology|December 4, 2003
Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosisLisa Y Zhao, Daiqing Liao
Cancers|July 2, 2021
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast CancersAaron R Waddell, Haojie Huang, Daiqing Liao
Pageof 4